| Abstrakt: |
A recent report from the Second Affiliated Hospital of Guangzhou Medical University in China discusses the potential for novel approaches to treating Sjogren's syndrome, an autoimmune disorder that affects the exocrine glands and causes dry eyes and mouth. The report highlights the need for a molecular-target-based approach to biologic therapy development and emphasizes the importance of addressing extraglandular symptoms such as fatigue and depression in clinical trials. The researchers suggest that emerging biologic agents targeting cytokines, signal pathways, and immune responses could be effective in treating the disease. They also propose that gene, stem-cell, and tissue-engineering therapies may play a role in future treatment options. [Extracted from the article] |
